Tracking the Evolution of Non-Small-Cell Lung Cancer.
Jamal-Hanjani, Mariam; Wilson, Gareth A; McGranahan, Nicholas; Birkbak, Nicolai J; Watkins, Thomas B K; Veeriah, Selvaraju; Shafi, Seema; Johnson, Diana H; Mitter, Richard; Rosenthal, Rachel; Salm, Max; Horswell, Stuart; Escudero, Mickael; Matthews, Nik; Rowan, Andrew; Chambers, Tim; Moore, David A; Turajlic, Samra; Xu, Hang; Lee, Siow-Ming; Forster, Martin D; Ahmad, Tanya; Hiley, Crispin T; Abbosh, Christopher; Falzon, Mary; Borg, Elaine; Marafioti, Teresa; Lawrence, David; Hayward, Martin; Kolvekar, Shyam; Panagiotopoulos, Nikolaos; Janes, Sam M; Thakrar, Ricky; Ahmed, Asia; Blackhall, Fiona; Summers, Yvonne; Shah, Rajesh; Joseph, Leena; Quinn, Anne M; Crosbie, Phil A; Naidu, Babu; Middleton, Gary; Langman, Gerald; Trotter, Simon; Nicolson, Marianne; Remmen, Hardy; Kerr, Keith; Chetty, Mahendran; Gomersall, Lesley; Fennell, Dean A.
N Engl J Med
; 376(22): 2109-2121, 2017 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-28445112
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.
Lung Cancer: A Wily Genetic Opponent.
Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.
Postoperative radiotherapy for non-small cell lung cancer.
KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma.
Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis.
Lung cancer: current therapies and new targeted treatments.
Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies.
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma.
First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.